Form 8-K · Current report
UnitedHealth Group 8-K, filed Jul 16, 2026
- Filed
- CIK
- 0000731766
- Accession no.
- 0000731766-26-000191
Summary
UnitedHealth Group reported second-quarter 2026 revenues of USD 112.0 billion and earnings from operations of USD 8.0 billion, with earnings of 6.04 USD per share and adjusted earnings of 6.38 USD per share, and raised full-year 2026 adjusted earnings guidance to 19.50 to 20.00 USD per share. CEO Stephen Hemsley said the results and outlook reflect progress in simplifying operations and improving affordability and the health care experience for patients and care providers.
Key points
- Second-quarter 2026 revenues were USD 112.0 billion and earnings from operations were USD 8.0 billion, compared with USD 111.6 billion and USD 5.2 billion in the prior-year quarter.
- The medical care ratio was 86.7 percent, compared with 89.4 percent in the second quarter of 2025.
- UnitedHealthcare served 48.5 million consumers and reported revenues of USD 86.0 billion and earnings of USD 3.9 billion; Optum generated USD 65.7 billion in revenues and USD 4.0 billion in earnings.
- UnitedHealth Group repurchased USD 4.0 billion of its common stock through mid-July 2026 and is on track to repurchase at least USD 5.0 billion for the full year 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 16, 2026, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its second quarter 2026 results. A copy of the press release is furnished herewith as Exhibit 99.1. The press release also includes a hyperlink to a pdf document which is furnished herewith as Exhibit 99.2. Exhibits 99.1 and 99.2 are incorporated herein by reference. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.